Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
ORISE Research Participant, Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
J Immigr Minor Health. 2024 Dec;26(6):1062-1069. doi: 10.1007/s10903-024-01609-2. Epub 2024 Jun 7.
We assessed syphilis screening data from overseas medical examinations among U.S.-bound refugees to characterize seropositive syphilis cases and treatment from January 1, 2015, to December 31, 2018. During this time period, all refugees 15 years and older were required to undergo syphilis screening prior to resettlement to the United States. Of the 160,381 refugee arrivals who had a syphilis screening performed, 697 (434 per 100,000) were diagnosed with any stage (infectious or non-infectious) of syphilis. Among the 697 persons with seropositive syphilis, a majority (63%) were from the Africa region and were male (58%), and 53 (7.6%) were diagnosed with an infectious stage of syphilis. All infectious cases were treated prior to resettlement. This information suggests a comparable risk of infection among U.S.-bound refugees compared to a report of syphilis among U.S.-bound refugees from 2009 to 2013, indicating low rates in this population for at least a decade.
我们评估了 2015 年 1 月 1 日至 2018 年 12 月 31 日期间美国入境难民的海外体检梅毒筛查数据,以描述血清阳性梅毒病例和治疗情况。在此期间,所有 15 岁及以上的难民在重新安置到美国之前都需要接受梅毒筛查。在接受梅毒筛查的 160381 名难民中,有 697 人(每 10 万人中有 434 人)被诊断患有任何阶段(感染或非感染)的梅毒。在 697 名血清阳性梅毒患者中,大多数(63%)来自非洲地区,且为男性(58%),53 人(7.6%)被诊断为感染期梅毒。所有感染病例在重新安置前均得到治疗。这一信息表明,与 2009 年至 2013 年美国入境难民梅毒报告相比,美国入境难民的感染风险相当,表明该人群至少在过去十年中梅毒感染率较低。